Recombinant Stories

The recombinant vaccines market is poised for robust growth, projected to reach a promising revenue of US$2,440.6 million by the year 2028, supported by a commendable Compound Annual Growth Rate (CAGR) of 6.1%. This signifies a strong and steady upward trajectory for the market, reflecting increasing demand and advancements in the field of recombinant vaccines.

A highly overprotective Neteyam te Suli Tsyeyk'itan finds out by chance that (his finally officially adopted brother) Spider has been subjected to less than humane interrogation methods during his time at the RDA. ________________________ Part 2 of the „Keeping up with the Sullys" series on Archiveofourown.org